
Genetic Testing for Joubert Syndrome and Related Disorders: Journey to Understanding
Unlock insights into Joubert Syndrome. Genetic testing aids early diagnosis, management, and family planning, enhancing life quality for those affected by JSRD.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock insights into Joubert Syndrome. Genetic testing aids early diagnosis, management, and family planning, enhancing life quality for those affected by JSRD.

Explore the genetic testing advancements for Joubert Syndrome with Ocular Defect, enabling early diagnosis, personalized management, and insights for family planning.

Explore the role of genetic testing in keratoconus, aiding early detection, personalized treatments, and informed family planning to improve vision health outcomes.

Explore how genetic testing of the MYH9 gene aids in diagnosing and managing macrothrombocytopenia, enabling precise treatments and informed family planning.

Explore how genetic testing aids in diagnosing Madras Motor Neuron Disease, differentiating it from similar conditions, and guiding personalized treatment strategies.

Unlock the role of genetic testing in diagnosing medullary thyroid carcinoma. Discover how RET mutations like M918V influence early detection and personalized treatment.

Genetic testing revolutionizes Meier-Gorlin syndrome management by enabling early diagnosis, personalized treatments, and informed family planning, enhancing patient outcomes.

Explore Melorheostosis with Osteopoikilosis, a rare bone disorder, and how genetic testing uncovers mutations, aids diagnosis, and informs treatment strategies.